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Abstract
Expression quantitative trait (eQTL) studies are a powerful tool for identifying genetic vari-
ants that affect levels of messenger RNA. Since gene expression is controlled by a complex
network of gene-regulating factors, one way to identify these factors is to search for interac-
tion effects between genetic variants and mRNA levels of transcription factors (TFs) and
their respective target genes. However, identification of interaction effects in gene expres-
sion data pose a variety of methodological challenges, and it has become clear that such
analyses should be conducted and interpreted with caution. Investigating the validity and
interpretability of several interaction tests when screening for eQTL SNPs whose effect on
the target gene expression is modified by the expression level of a transcription factor, we
characterized two important methodological issues. First, we stress the scale-dependency
of interaction effects and highlight that commonly applied transformation of gene expression
data can induce or remove interactions, making interpretation of results more challenging.
We then demonstrate that, in the setting of moderate to strong interaction effects on the
order of what may be reasonably expected for eQTL studies, standard interaction screening
can be biased due to heteroscedasticity induced by true interactions. Using simulation and
real data analysis, we outline a set of reasonable minimum conditions and sample size
requirements for reliable detection of variant-by-environment and variant-by-TF interactions
using the heteroscedasticity consistent covariance-based approach.
Introduction
Gene-gene and gene-environment interaction effects on common human traits and diseases
have been difficult to identify [1]. Part of the challenge is the small effect size of genetic variants
on macro-phenotypes (e.g. disease status or anthropometric traits). Assuming that interactions
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have effect sizes of the same magnitude as marginal genetic effects, the sample size needed to
detect them can be up to an order of magnitude larger [2]. In order to circumvent this issue,
researchers have performed screening for interaction effects on intermediate phenotypes (e.g.,
gene expression, proteomic, metabolomic) that presumably are directly affected by genetic var-
iation in a causal pathway from variant to disease phenotype [3–6]. Indeed, reported marginal
effects of single nucleotide polymorphisms (SNP) on gene expression are often substantially
higher than those reported in genome-wide association studies (GWAS) of common traits and
diseases. It is reasonable to assume that the interaction effects will also be larger and therefore
easier to detect.
In this study we analyzed blood gene expression and genotype data from 121 subjects in the
ECLIPSE Study [7, 8] to test for interaction effects between cis-eQTL SNPs (i.e. SNPs within
250kb of any autosomal gene) and the expression levels of transcription factors (TFs), since
one of the known mechanisms for expression quantitative trait loci (eQTLs) is disruption of
TF-binding motifs [9]. However, after careful evaluation of empirical performance of standard
methods, we found that Type I error rates can be severely inflated. In particular, we show
through simulations that genome-wide interaction screening in the setting of moderate to
large main and interaction effects poses two major challenges. The first challenge relates to
data pre-processing. Heavy pre-processing is commonly applied to gene expression data to
account for variability across samples, libraries, or experimental conditions [10–12]. Choices
made at this stage can impact the results of interaction screening, and while some approaches
likely address specific technical artifacts more effectively, no pre-processing strategy is known
to be universally best [13, 14]. Pre-processing often also includes variable normalization to
obtain approximately-Gaussian data, which can help the small-sample performance of testing
approaches (see e.g. [3, 4]). However, interaction effects are scale-dependent [15–17] and non-
linear transformation of the data can have a major impact on the interpretation of interaction
tests. The second challenge relates to statistical issues that arise in the presence of moderate to
strong interaction effects. We and others showed in previous work that interactions can influ-
ence the distribution of a quantitative trait conditional on the interacting predictors [18, 19].
For small interaction effects, as expected for most human traits and diseases, the impact on the
outcome distribution is expected to be minimal. However, moderate to strong interaction
effects can induce substantial heterogeneity of variance by genotypic class, which can in turn
lead to inconsistent covariance matrix estimation. Non-constant variance can induce uncon-
trolled Type I error rates and decreased power. This implies that the presence of a strong inter-
action between two predictors (e.g., a SNP and a TF) can potentially invalidate screening for
interaction effect between the interacting SNP and other risk factors.
Using simulation we investigate these issues by quantifying the performance of five analyti-
cal strategies to detect interaction: standard linear regression, two heteroscedasticity-consistent
covariance estimates, dichotomizing the predictors, and a saturated model. More specifically,
we assessed the robustness of these approaches when heteroscedasticity has been induced
through interaction effects while varying sample size, minor allele frequency and the magni-
tude of the main and interaction effects simulated. We identify minimal conditions necessary
for valid tests of interaction in eQTL studies. Finally, for illustration purposes, we also present
the results from the TF by SNP interaction screening in ECLIPSE. This real data analysis con-
firms the findings of our simulations, highlighting that standard approaches might have
severely inflated type I error rate. Moreover, we observed that the list of significant associations
changed dramatically across approaches, especially when comparing analyses of transformed
versus untransformed gene expression data, stressing that the two sets of analyses capture dif-
ferent patterns in the data.
eQTL interaction
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Results
Impact of non-linear transformation of expression data
Gene expression data are heavily pre-processed (Fig 1). We assume here the first two stages of
pre-processing result in the removal of most sources of technical variability. We examined the
impact of non-linear transformations (step 3 in Fig 1) and rank-based inverse normal transfor-
mations (rkt) in particular, as the latter approach is commonly applied in eQTL studies. Apply-
ing rkt on expression data can have several advantages. First, if the data show deviation from
normality (e.g., has an exponential-like distribution or skewness), rkt can increase the statisti-
cal power to detect the linear marginal effect of a predictor. In brief, non-linear transformation
can achieve a normal and homoscedastic distribution of points around the regression line,
potentially allowing for a larger amount of the outcome variance to be captured, thus increas-
ing power [20, 21]. However, this is not an absolute rule and it should be noted that rkt can
also decrease power in certain scenarios [21]. Overall, non-linear transformations that preserve
Fig 1. Gene expression data pre-processing pipeline. Standard pre-processing methods applied to gene expression data prior to
expression quantitative trait locus analysis. Note that alternative strategies are also used. For example step 2 is sometimes skipped and
confounding factors (e.g. batch) are included in the model tested as covariates. Others have also applied step 3 before step 2.
https://doi.org/10.1371/journal.pone.0173847.g001
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ranks are unlikely to induce false signals for marginal effects, and they are a valid alternative to
non-linear regression when the distribution of the error is not normal [22]. Indeed, previous
studies used ranks instead of raw data to identify upregulated genes [23, 24]. Another advan-
tage of rkt is that it addresses outlying values while preserving sample size. Expression data
often has noise-induced outliers (i.e., a few individuals with high expression values) because of
experimental artifacts or stochastic properties of the biological system, which can lead to an
increased rate of type I and type II errors [25]. The naive correction based on removing outli-
ers can substantially reduce sample size. Rank-based normalization allows for those subjects to
be retained.
However, in contrast to screening for marginal effects, rkt might have a stronger impact on
Type I and Type II error rates when testing for interaction [21, 26]. More generally, non-linear
transformations such as rkt can dramatically impact the interpretation of interaction effects. In
particular, while differences in significance before and after transformations are expected to be
relatively minimal when interaction effects are small (e.g. r2<1%, as in genome-wide associa-
tion studies of common traits and diseases), this is not necessarily the case when the variance
explained by predictors is large. Consider for example the generative model defined in Eq (1)
(see Material and methods) where the expression of gene Y depends on a SNP G, an exposure
E interacting with G (mRNA levels of a transcription factor in our case), and the residual ε fol-
lows a skewed-normal distribution with mean 0 and variance 1 (in order to reflect deviation
from normality as observed for some gene expression data). Note that for simplicity, we
assume the covariate Z has no effect (γz = 0) on Y. In the absence of interaction effect (γGE = 0),
if E and G explain a relatively large amount of the variance of Y (e.g., r230%, see Fig A in S1
File, doing a rank-based inverse normal transformation of Y (or other type of non-linear trans-
formation) can induce a statistical interaction between G and E. For illustration, we plotted in
Fig 2 two representative scenarios of transformation inducing or removing interaction. One of
the examples is where the generative model does not include interaction, while the rank-nor-
mal transform data does; and the second example illustrates the opposite case where the gener-
ative model does include an interaction between G and E, but the rank-normal transformed
data does not. Note that we considered a non-normal residual as it can be an argument for
applying a rank-based inverse normal transformation, but similar issues might arise when the
residuals are normally distributed. Figs B-C in S1 File further illustrate how rank-based trans-
formation can induce interaction when none is present on the original scale. While the scale-
dependency of interaction effects has been demonstrated previously [15–17], this issue is infre-
quently addressed in gene expression interaction analyses. Commonly applied non-linear data
transformations should be accounted for in the analysis and interpretation of interaction
effects in gene expression data.
The paradox of interaction effects
The second major challenge we found is that while weak interaction effects between two risk
factors are unlikely to have a noticeable impact on the conditional distribution of the outcome,
this is not the case for moderate to strong interactions. For an interacting SNP, this will be
expressed through heterogeneity of variance of the outcome residual by genotypic class, a
property that has been proposed as a target for interaction screening (using heterogeneity of
the outcome’s variance as a proxy for the residual’s variance) [6, 18, 19]. Heteroscedasticity
can cause the usual standard error estimates of ordinary least square coefficients to be incon-
sistent, thereby invalidating tests for interaction between that SNP and other risk factors
(excluding the true interacting factor which would be under the alternative) [27]. To illustrate
this point we conducted a simulation study using the model previously described (Eq (1), see
eQTL interaction
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Fig 2. Effect of non-linear transformation on interaction effects. We defined an outcome Y as a function of a single nucleotide
polymorphism G with a minor allele frequency of 0.1, an exposure E normally distributed with mean 5 and variance 1, and a right-
skewed normal distributed residual term ε. In the framework of this analysis, TF mRNA level is considered as an exposure E. We
generated two datasets of 10,000 individuals for the two scenarios. In a) G and E have only main effects and each explain 20% of the
variance of Y. In b) G and E main effects each explain 10% of the outcome variance, but also have an interaction effect explaining 20%
of the variance of Y. Upper panels show Y as a function of E by genotypic class and trend slope from a standard linear regression.
Lower panels show the same data plotted after a rank-normal transformation (rkt) of Y. Interaction effect (observed as differences in
slope by genotypic class) appears or disappears depending on the transformation applied to Y. P-values for interaction are indicated in
red.
https://doi.org/10.1371/journal.pone.0173847.g002
eQTL interaction
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Material and methods), but assuming the true interacting factor, E, unknown, and drawing ε,
the residual from a normal distribution with variance scaled so that the variance of Y is one for
all scenarios simulated. For simplicity we also assumed that E and Z follow normal distribu-
tions with mean 0 and variance 1. We tested for interaction between G and the non-interacting
factor Z in a series of replicates simulated in the presence or absence of main effects for G, E
and Z, as defined in Eq (2) (see Material and methods).
Fig 3 illustrates how moderate to strong interaction effects can induce variance heterogene-
ity of the outcome residual (δ) by genotypic class, resulting in inflation of the type I error rate
of the interaction tests between G and Z. This is in agreement with previous work, also show-
ing type I error inflation when misspecifying the main genetic effect [28–30]. Variance hetero-
geneity mostly depends on the strength of the interaction effect and the main effect of the
(unmeasured) exposure, although increasing main effects of the tested interacting factor (here
G and Z) can also worsen the type I error inflation (Fig 3 and Text A in S1 File). Assuming the
magnitude of the interaction effects are similar to the marginal genetic effects observed in cis-
Fig 3. When a true interaction can bias interaction screening. A quantitative outcome Y is defined as a linear function of a SNP G, an unmeasured
exposure E, a measured exposure Z, and an interaction between G by E, with effect γG, γE, γZ, and γGE, respectively (as defined in Eq 1). All predictors
were standardized to have mean 0 and variance 1. In the framework of this analysis, TF mRNA level is considered as an exposure E. We vary γGE so that
the interaction term explains between 0 and 30% of the variance of Y. For simplicity we assume that, when relevant, the main effect of either G, E, or Z
explains the same amount of variance as the interaction effect and set ε so that the variance of Y equals 1. Using this model we simulated series of 10,000
replicates, each including 400 individuals and tested for interaction between G and Z using a model not including the unmeasured exposure E (as defined
in Eq 2), in the absence of main effect of the predictors (γG = γE = γZ = 0), panel a) or when including a main effect of G (γG 6¼ 0, panel b), a main effect of E
(γE 6¼ 0), panel b), or a main effect of G (γZ 6¼ 0, panel d). Upper panels show the increase in the residual variance of the outcome δ minus ε (so that models
are comparable) stratified by genotypic class while increasing the interaction effect γGE. Lower panels show the type I error rate α at a p-value threshold of
0.05 for the interaction tests between G and Z derived for each series of 10,000 replicates.
https://doi.org/10.1371/journal.pone.0173847.g003
eQTL interaction
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eQTL screening (e.g., r2>30%, see Fig A in S1 File), this analysis demonstrates that genetic
variants found to have significant interactions with multiple factors should be interpreted with
caution, as this may indicate that the tested SNP is involved in a strong interaction with some
factors, but not necessarily with the factors tested. The key point here is that in a simple model,
assuming covariates included in the model are not confounding factors of the predictors
tested, heteroscedasticity caused by a strong interaction between the tested variant and an
unmeasured factor (or at least a factor not included in the model) can induce spurious interac-
tion effects with other non-interacting factors. Note that heteroscedasticity generated by inter-
action would only be a limited concern for the test of the marginal genetic effect. Indeed G
being involved in an interaction means it is related to the outcome tested, and while power
and effect estimation might be impacted, a marginal effect association signal with G would
likely represent a true signal.
Correcting for inflation
We then extended our simulations to assess the validity of five approaches in the presence of a
strong interaction between the SNP tested and an unmeasured factor. As before, we assumed
that the gene expression data have been corrected for technical artifacts but not rank trans-
formed (step 1 and 2 in Fig 1). We considered first standard linear regression without further
correction (Eq 2). We then considered the heteroscedasticity consistent (HC) covariance-
based approach. A number of alternatives have been proposed to deal with this issue [31], and
while some might perform better than others, a complete comparison of these methods is
beyond the scope of this study. Therefore we focused on the two most established approaches,
the sandwich covariance matrix estimator (HC0) proposed by White [27], and the jackknife
HC covariance (HC3), which has been suggested as the most efficient approach to deal with
heteroscedasticity in small sample size [32]. Both methods are commonly used in genetic asso-
ciation studies [28, 33, 34]. As proposed for GWAS, we also considered two other methods
that address model misspecification [30], namely dichotomizing the exposure Z, and using a
saturated model that includes non-linear main effects of the predictors. For the latter approach
we simply included in the model a main effect for Z2 and for each genotypic class (G = 1 and
G = 2).
We compared the robustness of the five approaches across a series of one million simulated
replicates for the null model of no interaction between G and Z. We considered 96 different
scenarios, increasing sample size from 100 to 5,000 (reflecting sample size in recent analyses
[3, 4, 6]), increasing the coded allele frequency (CAF, analogous to minor allele frequency in
this case) from 0.05 to 0.5, assuming normal or a skewed normal distribution for the three con-
tinuous variables of the experiment (E, Z and ε), and assuming alternatively presence or
absence of a main effect for Z. The magnitude of the G × E interaction effects and the main
effects of the predictors (E, G, and Z when relevant) were generated at random for each repli-
cate. As shown in the QQplots from Fig D-K in S1 File, sample size and CAF had the strongest
impact on the results, while we observed minor differences when varying the other parameters.
Fig 4 presents the average performance of the five tests across the two former parameters (the
sample size and CAF). This simulation shows that tests for interaction in small sample sizes
(<100) are subject to strong type I error rate inflation for all studied methods. This inflation
decreases with increasing sample size, however it can remain substantial for low frequency var-
iants. Moreover, the inflation is non-linear, meaning that genomic control (GC) correction
[35] cannot ensure the validity of the test. Overall, HC3 had the best performance, displaying
an inflation factor λ close to 1 and only minor or no inflation of low p-values when using a
sample size of 1000 or greater and common SNPs (CAF 0.3).
eQTL interaction
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Interaction effect screening in ECLIPSE
To illustrate these effects in real data, we conducted a two-step screening approach to identify
interaction effects between cis-eQTL SNPs and candidate TFs in a genome-wide expression
dataset from 121 subjects in the ECLIPSE Study [36]. Interaction triplets (SNP, TF and target
gene) were defined based on an a priori list of TFs and significant SNP-gene pairs from the
Fig 4. Robustness comparison. QQplots over series of 8 million replicates where an outcome Y is simulated as a function of a genetic variant G, an
unmeasured exposure E, an interaction between G and E, and in 50% of the replicates a measured exposure Z. In the framework of this analysis, Z and E
are considered as measured and unmeasured TF mRNA level, respectively. The validity of five tests is evaluated by comparing the observed -log10 (p-
value) against the expected -log10 (p-value) when testing for the null interaction between a G and Z. The tests include a standard linear regression using
main and interaction terms only (STD), heteroscedasticity consistent-based tests using effect estimates from STD (HC0 and HC3), linear regression using
binary-transformed Z (BIN), and a saturated model including a main effect of Z 2 and each genotype coded as dummy variable (SAT). We considered
coded allele frequency (CAF) of 0.05 (first row), 0.3 (middle row) and 0.5 (bottom row), and sample size N of 100, 500, 1,000 and 5,000. We randomly
draw E, Z, and ε, the residual of Y from either a normal or a right-skewed normal distribution. For each scenario we derived the genomic inflation factor
λGC.
https://doi.org/10.1371/journal.pone.0173847.g004
eQTL interaction
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ECLIPSE cis eQTL analysis. We followed the pre-processing procedure of Fig 1, except for
part 3 (i.e., no rank-based inverse normal transformation). Step one consisted of testing all
SNPs in the vicinity of a gene for cis-effect on the expression of that gene assuming an additive
genetic effect and using a score test as implemented in the GGTools software [37], and to select
the most significant cis-eQTL as candidate SNPs for interaction effect testing. Among the
18,834,685 gene-SNP pairs tested, we identified 132,074 SNPs with a q-value for association
less than or equal to 0.01. From these results we selected the most significant SNP for each
Affymetrix probe set, resulting in a total of 2,982 cis-eQTL SNPs associated with 3,334 target
probe sets. As observed in other studies, the variance of the residualized expression phenotypes
explained by cis-eQTL SNPs can be much larger than those observed for quantitative pheno-
type in human GWAS [38]. Fig A in S1 File presents the distribution of r2 obtained from mar-
ginal genetic model for the 3,334 pairs. The average equals 0.45 with a maximum r2 of 0.87. In
comparison, under a null model with the same total number of tests and using the same p-
value threshold, we would expect to observe a distribution of effects to have a mean r2 of 0.14
and a maximum of approximately 0.25.
In step two, all cis-eQTL SNPs selected at step one were tested for interaction with the
expression level of candidate TFs obtained from the publication by Vazquerizas et al [39]. To
reduce the multiple testing burden, candidate TFs were tested for interaction with a given gene
only if their marginal association with the target probe set was nominally significant (p<0.05).
Also, to avoid confounding by a cis-effect of a SNP on two genes in close physical proximity,
all TFs within 10Mb of a candidate cis-eQTL SNP were not tested for interaction with that
SNP and its target gene. Among 1494 TFs, 1292 TFs represented by 2,896 probesets were avail-
able for analysis in the ECLIPSE study. As shown in Fig A in S1 File, the variance of the target
gene explained by candidate TFs was high, with an average r2 of 0.35. Overall, there were
745,943 trios (target probe-set, cis-eQTL, and candidate TF) to be screened for interaction
effects. For each of these trios we performed the standard linear regression on non-rank trans-
formed data (std) and inverse-normal rank-transformed data (rkt), and we considered for both
approaches the HC3 correction of the effect estimate variance to account for heteroscedasticity
(h3 and rkt.h3, respectively).
Fig L in S1 File presents the QQplots observed for each of the four strategies. As in the sim-
ulations, we observed non-linear and strong inflation of low p-values, as measured by the
genomic control (λGC equal 1.36, 1.13, 1.22 and 1.10 for std, h3, rkt and rkt.h3, respectively).
There were 151, 244, 4, and 75 significant interactions after correction for multiple compari-
sons (P-value< 1.0x10-8), for std, h3, rkt and rkt.h3, respectively. While a few interactions
were significant or near significant across all tests, most showed strong heterogeneity. Table 1
presents the top five interactions from each approach as well as the corresponding p-value and
rank. Unsurprisingly, all SNPs from Table 1 had a strong marginal effect on the target gene.
For example, rs8109474 explained 63% of the variance of target probe set 218824_at
(PNMAL1). The significance of the interaction was also strongly correlated with the strengths
of the marginal association between the candidate TF and the target probe set. As shown in
Fig 5, λGC value for the std interaction test increases to almost 2 when focusing on the candi-
date TFs showing the strongest association with the target gene. While some of the observed
λGC inflation might due to a true enrichment for interaction effects, a substantial part of the
association is likely due to statistical artifacts. Conversely, the rkt test, which corrects for the
effect of outliers and potentially reduces inflation caused by interaction between SNPs and
unmeasured factors (Table A in S1 File), shows lower inflation (average λGC = 1.17). In addi-
tion, rkt appears to be stable when focusing on TFs with increasing association with the target.
Assuming strongly associated TFs are more likely to have biological interaction with cis-eQTL
eQTL interaction
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Table 1. Top 5 interaction signals for four different analytical strategies.
SNP Target TF P-value (rank*)
STD HC3 RKT RKT.HC3
rs8109474 PNMAL1 NR3C2 6.8E-17 (1) 2.0E-15 (7) 1.3E-05 (510) 1.6E-06 (530)
rs8109474 PNMAL1 SOX13 5.2E-16 (2) 2.7E-07 (671) 1.8E-05 (630) 1.5E-04 (5648)
rs8109474 PNMAL1 NFIA 8.2E-15 (3) 4.7E-17 (2) 3.6E-05 (1071) 1.6E-05 (1668)
rs8109474 PNMAL1 ZNF30 4.3E-14 (4) 5.1E-15 (8) 4.5E-04 (7844) 3.9E-04 (9999)
rs8109474 PNMAL1 ZBTB7C 1.3E-13 (5) 1.3E-07 (536) 3.7E-05 (1095) 1.1E-04 (4692)
rs364734 SLC17A5 ZFP1 1.1E-07 (367) 7.2E-18 (1) 5.9E-08 (7) 3.2E-07 (286)
rs8109474 PNMAL1 NFIA 8.2E-15 (3) 4.7E-17 (2) 3.6E-05 (1071) 1.6E-05 (1668)
rs62323426 LINC01091 SP2 1.8E-12 (16) 1.7E-16 (3) 3.7E-04 (6763) 2.9E-06 (717)
rs8109474 PNMAL1 ZNF74 4.0E-10 (56) 4.2E-16 (4) 6.9E-04 (11021) 1.3E-04 (5187)
rs8109474 PNMAL1 NFAT5 1.0E-11 (23) 7.2E-16 (5) 1.2E-04 (2678) 1.1E-06 (470)
rs4872978 LINC00293 GATA5 1.5E-07 (427) 1.1E-05 (2889) 5.0E-09 (1) 1.9E-04 (6619)
rs4872978 LINC00293 PAX2 3.4E-10 (54) 0.52 (2600803) 6.0E-09 (2) 5.8E-09 (61)
rs4872978 LINC00293 FOXD3 2.6E-11 (26) 8.5E-11 (58) 6.9E-09 (3) 2.1E-04 (7034)
rs4872978 LINC00293 GATA4 8.7E-09 (142) 2.1E-07 (628) 7.6E-09 (4) 4.8E-09 (57)
rs4872978 LINC00293 DLX6 4.3E-10 (57) 1.6E-08 (280) 1.9E-08 (5) 1.9E-03 (27599)
rs17561351 PVRL2 FOSL2 2.5E-06 (1321) 1.2E-10 (65) 5.0E-04 (8579) 4.6E-15 (1)
rs61001363 UACA ZNF496 7.7E-07 (797) 5.7E-10 (103) 1.9E-06 (127) 2.0E-13 (2)
rs11983315 TMEM209 FOXN3 1.0E-05 (2456) 6.0E-07 (938) 1.7E-04 (3645) 1.1E-12 (3)
rs254057 SKP1 BCLAF1 7.8E-04 (29906) 2.5E-08 (326) 1.2E-03 (16692) 2.1E-12 (4)
rs7657290 SCOC TP63 2.0E-02 (257900) 2.3E-10 (79) 4.6E-03 (50506) 2.3E-12 (5)
Abbreviations: STD, standard linear regression; HC3, heteroskedastic variance estimator; RKT, rank-transformed variables; TF, transcription factor.
* Rank of the SNP-target interaction test on the TF over all test performed
https://doi.org/10.1371/journal.pone.0173847.t001
Fig 5. Distribution of interaction test lambdaGC in ECLIPSE. We derived the genomic inflation factor (λGC) of the standard
interaction test using across sub-groups stratified based on PTF.marg, the p-value for association between the target gene and the
candidate transcription factors (TFs). Grey bars present the total number of interaction tests falling in each strata. Four approaches
were performed: i) no normal rank-transformation of the expression data (std), ii) HC3 correction of the effect estimate variance to
account for heteroscedasticity (h3), iii) normal rank-transformation of expression data (rkt), and iv) HC3 correction and normal rank-
transformation of expression data (rkt.h3).
https://doi.org/10.1371/journal.pone.0173847.g005
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SNPs, this flat curve raises the potential concern that, in agreement with our simulations, inter-
action effects on the original scale might be removed by the rkt transformation.
Discussion
Genomic data, and gene-expression data in particular, offer new opportunities to identify
gene-gene and gene-environment interactions. In this study we attempted to screen for SNP
by TF interaction on gene-expression using data from the ECLIPSE study, and we describe
two methodological issues related to the detection and interpretation of statistical genomic
interactions. First, interaction effects are scale-dependent and commonly applied pre-process-
ing steps that perform non-linear transformation of expression data can induce or remove sta-
tistical interaction, making interpretation of results more challenging. Second, the effect sizes
observed in eQTL data are substantially larger than those observed for genetic association with
complex human traits and diseases. Assuming interaction effect sizes are similarly large, our
simulations show that their presence can induce substantial heteroscedasticity, which itself can
impact the robustness of interaction test screening. While heteroscedasticity and scale-depen-
dent effects have been discussed in a broader context, recent screening for interaction effects
in gene expression data have not specifically addressed these issues [3, 4, 6]. We used simula-
tion and real data analysis to explore these issues and evaluate the performance of analytical
strategies that avoid non-linear transformation of gene expression (step 3 in Fig 1) while pre-
serving robustness. Our analysis suggests that using the jackknife heteroscedasticity consistent
covariance (HC3) correction without applying rank-based inverse normal transformation
would be the best approach if sample size is large enough.
Rank-based inverse normal transformation, as well as other non-linear transformations of
expression data, can have both positive and negative impact on interaction screening. It
removes outliers and assures that the marginal distribution of the phenotype is normal, thus
enabling better properties of interaction screening under a complete null model (i.e., in the
absence of both main and interaction effect). We also observed in simulated data that hetero-
scedasticity induced by true interaction effects is partly reduced after applying rkt (Table A in
S1 File). This partially explains the apparent overall better behavior of the rkt test in the
ECLIPSE data analysis. However, previous work showed that rkt is an imperfect solution,
because it can impact both type I and type II error rate [21, 26]. Moreover, because it alters the
outcome scale, rkt can potentially remove the targeted interaction effect and/or induce statisti-
cal interaction effects across other SNPs. The question of determining the appropriate scale for
interaction testing is a critical issue that remains to be addressed. Rank-based inverse normal
transformation or other non-linear transformations that are performed as standard practice
for most gene expression analyses fundamentally alter the meaning of statistical interaction in
a way that should be explicitly recognized in an interaction analysis. The recent focus on
RNA-Seq analysis methods provides an opportunity to revisit this issue. RNA expression is
fundamentally heavy-tailed, and many RNA-Seq methods use the negative binomial distribu-
tion to model these data, as opposed to the standard quantile normalization and linear model-
ing approach for microarray data [40]. For the detection of statistical interaction, it is less
important to identify a “correct” scale for the analysis, than it is to specify a specific hypothesis
for biological interaction and then choose the appropriate scale of the data so that detected sta-
tistical interactions will represent biological interactions of interest. From this standpoint, we
suggest limiting data transformations and analyzing data on their native scale, though this
approach does introduce methodological challenges related to the statistics of non-normal
distributions.
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Our simulations also demonstrate that an interaction between two factors can induce spuri-
ous statistical interaction effects between those factors and other non-interacting factors, lead-
ing to the paradoxical situation where the interaction effect screening can be invalid under the
scenario of strong interaction. Exploring alternative solutions, we found that interaction effect
screening can likely be performed safely among common SNPs (minor allele frequency,
MAF 5%) in large sample sizes (N 5,000) using the HC3 correction, while for smaller sam-
ple size (N 1000), there will remain uncertainty on the validity of association signal. This
result is complementary to previous publications highlighting other challenges in genomic
interaction screening. In particular, there has been controversy regarding the validity of previ-
ously reported [3] SNP-SNP interactions in eQTL analysis [41, 42]. These studies highlighted
that testing for cis-cis interaction effects should be interpreted with caution, as an observed sta-
tistical interaction may reflect a haplotype effect. While our analysis focused on SNP-by-TF
interactions, SNP-SNP interactions would likely face the issues discussed in our study, as the
increased type I error rate we observed was driven by the hidden interaction between the SNP
tested and an unmeasured quantitative trait, independently of the other tested interacting fac-
tor (another SNP in a SNP-SNP interaction screening).
We acknowledge that the proposed strategy does not necessarily represent the optimal solu-
tion. To fully address scaling and robustness issues, future work might explore alternatives to
the HC3 correction that better model the data (e.g., tests that specifically model residual and
predictor distributions) and also assess the impact of common pre-processing practices such
as log transformation of raw expression values, quantile normalization [10], adjustment for the
principal components of expression [11], and other procedures meant to reduce technical vari-
ability [43]. Various combinations of these corrections have been proposed either separately
[13] or in an integrated framework [44]. With the exponential increase of genomic data, the
validity and performance of existing approaches has been widely discussed for marginal associ-
ation screening [12, 13, 45–47], and best practices evolve continuously with new methodologi-
cal developments and the rise of new technologies. While the proposed approach is an
important step toward more robust and interpretable interaction effects screening in genomic
data, identifying the optimal analytical strategy will similarly follow an iterative process with
additional theoretical work and validation from real data applications.
Material and methods
Non-linear transformation of expression data
We generated an outcome Y as a function of a SNP G, an exposure E and a covariate Z using
the following generative model:
Y ¼ g0 þ gGGþ gEE þ gGEGEþ gZZ þ ε ð1Þ
where γ0, γG, γE, γZ and γGE are the intercept and the effects of G, E, Z and the interaction effect
between G and E, respectively; and ε is the residual. We set the minor allele frequency of G at
0.1, and generated E using a normal distribution with mean 0 and variance 1. We considered
two scenarios. In the first one, G and E have only main effects, each explaining 40% of the out-
come variance, but they do not interact (γGE = 0). In the second scenario, only E has a main
effect (γE 6¼ 0) and (γG = 0), while G has no main effect but influences Y through its interaction
with E. The residual ε is generated following a right-skewed normal distribution and is scaled
so that the variance of Y equals 1. For each scenario we plotted Y and rkt(Y) as a function of E,
where rkt() is a rank-based inverse normal transformation function. The rkt transformation
was performed using the R function rntransform() from the GenABEL R package. We then
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estimated the effect of E on both Y and rkt(Y) by genotypic class using standard linear
regression.
Effect of true interaction on interaction screening
To explore the impact of true interaction effects, we then generated a series of data using
Eq (1). For simplicity we standardized all predictors to have mean 0 and variance 1. We vary
γGE, the interaction effect between G and E, so that the variance of the outcome explained by
the interaction τG×E varies from 0 to 30%, where τG×E = var(γGEGE) / var(Y). Note that τG×E is
similar to the standard definition of variance explained by interaction effects as all predictors
are standardized, however this would not be the case for unstandardized predictors [2]. For
simplicity we also assumed that, when relevant, the main effects of either G, E, or Z explain the
same amount of variance as the interaction effect. We draw ε, the residual of Y, from a normal
distribution with mean 0 and variance scaled so that the unconditional variance of Y equals 1.
From this model we generated a series of 10,000 independent replicates of 400 individuals and
we conducted a test of b^GZ, the estimated interaction effect between G and Z from the model:
Y~bGGþ bZZ þ bGZGZ þ d ð2Þ
We generated multiple series of data from this model in the absence of main effects (γG = γE
= γZ = 0), including a main effect of G (γG 6¼ 0), a main effect of E (γE 6¼ 0), or a main effect of
G (γZ 6¼ 0). We first evaluated the relationship between τG×E and δ the residual variance of the
outcome from Eq (2), when stratifying by genotypic class. However, to allow for a clearer com-
parison we also subtracted ε from δ (see Supplementary Note). We then derive for each simu-
lated scenario the type I error rate α of βGZ, the interaction tests between G and Z, at a p-value
threshold of 0.05, defined as ðSNspGZ  aÞ=Ns, where Ns the number of simulations equals
10,000 and pGZ is the p-value of the interaction effect.
Correction for statistical tests
We considered standard linear regression and four alternative approaches that can potentially
correct for the non-linear effect of the predictor in the interaction tests. First, we used two het-
eroscedasticity consistent covariance-based approaches. In brief, we used the interaction effect
estimate ðb^GZÞ from Eq (2) and derived s^bGZ jHC, the standard deviation of the interaction term,
using HC0 and HC3 formulation using the vcov() function from the Sandwich R package. We
then derived the Wald test for each updated variance estimates, wHC0 ¼ b^
2
GZ=s^
2
bGZ jHC0
and
wHC1 ¼ b^
2
GZ=s^
2
bGZ jHC3
, and their associated p-values. The third correction entails using a dummy
variable for Z instead of the raw continuous coding. The dummy variable, Zbin, equals 0 for val-
ues of Z smaller than its median and 1 otherwise. The interaction test is then performed by
evaluating the term bGZbin from the following model:
Y~bGGþ bZZbin þ bGZbinGZbin þ d ð3Þ
The last correction entails using a saturated model where the main effects of the interacting
factors (here, G and Z) are modelled using additional terms. Various saturated models can be
built. In these analyses we defined a model that includes a main effect of Z2 and encodes the
main effect of the genotype using two dummy variables corresponding to G = 1 and G = 2. We
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tested b
0
GZ, the interaction effect between Z and G, using its ordinal coding:
Y~bG1G1 þ bG2G2 þ bZZ þ bZ2Z
2 þ b
0
GZ GZ þ d ð4Þ
We generated a series of 1 million replicates using the model from Eq (1) where γ = (γG, γE,
γGE, γZ) are randomly sampled from a uniform distribution (0,1). Unless otherwise specified,
continuous variables (E, Z and ε) were drawn randomly from a normal distribution or right-
skewed normal distribution, both with mean 0 and variance 1. The residual ε was further
scaled so that the variance of Y explained by the simulated predictors in Eq (1) would vary
from 0% to 80%. However, to explore the impact of deviation from normality for each of the
three quantitative variables (E, Z and ε) we also performed simulations while using a normal
distribution only for all replicates. We also compared scenarios where the either the true inter-
acting exposure E or the tested interacting exposure Z have a main effect against scenarios
where they have no main effect. Finally, we varied the sample size from 100 to 5,000 and the
frequency of the coded allele for G from 0.05 to 0.5. Overall, our simulations covered 96
scenarios.
The ECLIPSE data
Study participants included 121 COPD cases genotyped as part of the ECLIPSE study [36]
using the genome-wide Illumina HumanHap550 BeadChip. Each participant had data on ~6.1
million SNPs, either directly genotyped or imputed using the 1000 Genomes EUR reference
panel (March 2010) [48]. Details on quality control assessment, filtering of the SNPs and geno-
type imputation have been described elsewhere [49, 50]. Gene expression was measured from
whole blood samples on the Affymetrix HGU 133Plus 2.0 chip, and eQTL analysis was per-
formed as previously described [8]. Gene expression data were log-transformed and quantile
normalized using the RMA function in the “affy” R package [51] (step1 in Fig 1). We then
regressed expression values on age, gender, the first principal components derived from the
genotype data on all ECLIPSE participants [52], and the first 13 principal components from
gene expression, retaining residuals from this regression for further eQTL analysis (step2 in
Fig 1). Genotype data of all samples used in this study are available in dbGap (phs001252.v1.
p1, in process). ECLIPSE expression data has been previously submitted to GEO as part of
another project (229 samples) with GSE76705. Note that the ECLIPSE dbGaP submission
(phs001252.v1.p1, in process) will also contain links to the GEO expression data.
Supporting information
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